Innovative treatments and cures are an integral part of our health care system and can help patients live longer, healthier lives. But vital medicines only work if patients have access. To ensure medical innovation continues to benefit patients, medicines must be both affordable and accessible.
LATEST ARTICLES
-
Providing Patients with Cost Information and Tools to Navigate Insurance Coverage
The biopharmaceutical industry is dedicated to finding lifesaving treatments but also making sure patients can access them.
-
World Health Day: How Do We Afford the New Era of Medicine?
For World Health Day, the World Health Organization reminds us that “everyone, everywhere should be able to access essential, quality health services without facing financial hardship.”
-
Patient Resources
America's Biopharmaceutical Companies are researching and developing thousands of new treatments and cures, and helping more patients every day.
-
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
RELATED ARTICLES
How Intellectual Property Protections Spur Innovation
Strong IP protections are critical to safeguarding innovation within the biopharmaceutical industry.
Researcher Profile: Stephanie Bartner
Stephanie’s interest in becoming a research analyst for Sanofi was personal.
Fixing Medicare for America’s Seniors
Ensuring timely, affordable access to new medicines for seniors has never been more vital.
Changes to the Health Care System Should Prioritize Patient Affordability
A group of experts recently discussed the ways we can realign the U.S. health care system to improve access and affordability for patients.
3 Groundbreaking Innovations That Were First Approved in the United States
Breakthrough therapies are approved in America quickly, and this translates to hope for patients and families.
Why Washington Shouldn't Copy the Flawed Pricing Policies of Other Countries
America is the world's leading source of innovation. Let's keep it that way.
Moving Toward a Value-Driven Health Care System
To advance a value-driven care system, we need better information, a focus on outcomes that matter to patients and flexible new approaches to paying for medicines.
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford innovation by reading the story of David Cobden, Ph.D., who works to pursue new payment models for a variety of cutting-edge treatments.
Innovation is Fragile, But Worth Protecting
The Atlantic, in partnership with PhRMA's GOBOLDLY campaign, convened thought leaders to discuss the policies needed to foster biopharmaceutical innovation while ensuring access and affordability for patients.
Achieving Innovation and Access Together
In today's new era of medicine, breakthrough treatments are revolutionizing how we fight disease, providing hope to patient populations that 20 years ago could never have dreamed of using the word "cure" when talking about their conditions.
Tackling Overdose and Addiction with Novel Treatments
In a few weeks, on August 31, the world will recognize International Overdose Awareness Day, which takes place each year and aims to raise awareness of overdose and to reduce the stigma of a drug-related death.
How the New Era of Medicine is Disrupting Health Care
We are on the cusp of a major, positive disruption in the U.S. health care system due in part to the exponential growth in clinical data, advent and incorporation of artificial intelligence and the increasing realignment of the health care sector.
Innovative Medicines Deserve an Innovative Payment System
Over the past several years, we've witnessed an unprecedented pace of innovation which has ushered in a new era of medicine.
Policy Solutions to Push Progress Forward
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
Our Commitment
We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough and dedicated to ending the burdens of disease. And with new, innovative medicines on the horizon, we're closer than ever to reaching our goal.
